knowledge -WSS

knowledge

author：focus 2025-10-03 00:07:05 - browse：529

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Grail is spending more than ever lobbying Congress

WSS

7 people shot in DC, police say

Doctor appointment wait times are getting worse

Pfizer's Covid pill remains 89% effective in final analysis, company says

Laying a path for careers in science

Childhood vaccination ad campaign launches in the U.K.

Virtual repurposing can help discover new uses for existing drugs

focus

knowledge

focus

Duchenne breakthrough therapy leaves behind pioneering families

Elisabeth Bik tackles the widespread issue of research misconduct

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Madness 2024: Meet the contenders

Guidelines to prevent youth baseball injuries need more muscle

Study fuels hope CAR

Tori Bowie and the unacceptable rates of Black maternal death

Pfizer's Covid pill remains 89% effective in final analysis, company says

23andMe had bad news about my health. I wish a person had delivered it

These geoengineering technologies could help combat the climate crisis, scientists say

knowledge

Neuroscience renaissance leads to new crop of psychiatric drugs

Pfizer's Covid pill remains 89% effective in final analysis, company says

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Option Care buys Amedisys in $3.6 billion home care deal

Can food be medicine? And other questions about a new push

leisure time

focus

Wikipedia

explore